Mithplatins: Mithramycin SA‐Pt(II) Complex Conjugates for the Treatment of Platinum‐Resistant Ovarian Cancers-Reference-Cited by-同舟云学术

Mithplatins: Mithramycin SA‐Pt(II) Complex Conjugates for the Treatment of Platinum‐Resistant Ovarian Cancers

Published:2022-11-22 Issue:3 Volume:18 Page:
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Bhosale Suhas S.¹^ORCID,Mandal Abhisek¹,Hou Caixia¹,McCorkle J. Robert²,Schweer David³,Hill Kristen S.²,Subramanian Vivekanandan⁴^ORCID,Kolesar Jill M.²³⁵^ORCID,Tsodikov Oleg V.¹^ORCID,Rohr Jürgen¹^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences College of Pharmacy University of Kentucky 789 S. Limestone Street Lexington KY 40536 USA

2. Markey Cancer Center University of Kentucky 760 S. Rose Street Lexington KY 40536 USA

3. Division of Gynecologic Oncology College of Medicine 760 S. Rose Street Lexington KY 40536 USA

4. University of Kentucky PharmNMR Center College of Pharmacy University of Kentucky Lexington KY 40536-0596 USA

5. Department of Pharmacy Practice and Science College of Pharmacy University of Kentucky 760 Press Avenue Lexington KY 40536 USA

Funder

National Cancer Institute

National Institutes of Health

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cmdc.202200368

Reference67 articles.

2. Cancer statistics, 2018

3. Ovarian cancer statistics, 2018

5. The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mithramycin and its analogs: Molecular features and antitumor action;Pharmacology & Therapeutics;2024-08

2. Organometallic analogs of chloroquine: Challenges and perspectives as anti‐malarial agents;Applied Organometallic Chemistry;2024-07-10